Radiopharmaceuticals in Development: Where We Are and What's Next


Don’t miss this opportunity to get an update on the current state of radiopharmaceuticals in development, along with an advanced look at trends for the near future. Expert presenters will offer pharmacists and technicians the regulatory, scientific, and clinical perspectives needed for the successful clinical translation of these novel therapies.

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Review preclinical evaluation requirements starting with drug discovery and up to toxicity/pharmacology assessment and dosimetry.
  2. Discuss the practical considerations during radiopharmaceutical development.
  3. Describe the IND enabling requirements.
  4. Discuss the theragnostic agents in research and development.

Joint Providership

This activity is approved for Board Certified Nuclear Pharmacist (BCNP) recertification credits.

Jason Lewis, PhD
Professor and Vice Chair
Radiology, MSKCC
Learning Level: Level 2
Track: Nuclear Pharmacy
Session Time Slot(s): 
Friday, March 20
11:30 AM - 1:30 PM
Gaylord National Resort - Chesapeake A-C
ACPE Pharmacist: 0202-0000-20-074-L04-P
CEUs Pharmacist: 0.2
ACPE Pharmacy Technician: 0202-0000-20-074-L04-P
Activity Type: